Literature DB >> 10528792

Genetics of rheumatoid arthritis (RA): two separate regions in the major histocompatibility complex contribute to susceptibility to RA.

D P Singal1, J Li, K Lei.   

Abstract

We analyzed HLA-DR antigens and microsatellite Bat2 alleles in 97 adult caucasian patients with classical seropositive rheumatoid arthritis (RA) and 95 normal healthy controls. The results demonstrate that the prevalence of microsatellite Bat2 138 allele was significantly higher in RA-susceptibility DRB1 QKRAA/QRRAA epitope-negative patients as compared with normal controls. Analysis of the data suggested that Bat2 138 allele has primary association with RA-susceptibility in QKRAA/QRRAA epitope-negative patients. The Bat2 138 allele thus provides an additional risk in RA-susceptibility. In addition, microsatellite Bat2 138 allele showed a highly significant positive association with microsatellite D6S273 138 allele, which has similar (identical) association with RA development in DRB1 QKRAA/QRRAA epitope-negative patients. The present data demonstrate that DRB1 QKRAA/QRRAA epitope and microsatellite Bat2 138/D6S273 138 alleles more completely define the risk for development of RA. The results in the present study therefore suggest that two regions in MHC, class II (DRB1) and class III (Bat2 and D6S273 in HSP70-Bat2 region), contribute to susceptibility to RA.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10528792     DOI: 10.1016/s0165-2478(99)00108-x

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  9 in total

Review 1.  Genetic bases of autoimmune hepatitis.

Authors:  Albert J Czaja; Derek G Doherty; Peter T Donaldson
Journal:  Dig Dis Sci       Date:  2002-10       Impact factor: 3.199

2.  Genome-Wide Identification of N6-Methyladenosine Associated SNPs as Potential Functional Variants for Type 1 Diabetes.

Authors:  Yang Chen; Min Shen; Chen Ji; Yanqian Huang; Yun Shi; Li Ji; Yao Qin; Yong Gu; Qi Fu; Heng Chen; Kuanfeng Xu; Tao Yang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-16       Impact factor: 6.055

Review 3.  Rheumatoid arthritis genetics: 2009 update.

Authors:  Robert M Plenge
Journal:  Curr Rheumatol Rep       Date:  2009-10       Impact factor: 4.592

Review 4.  Genomic markers of ovarian reserve.

Authors:  Michelle A Wood; Aleksandar Rajkovic
Journal:  Semin Reprod Med       Date:  2013-10-07       Impact factor: 1.303

5.  Association of the -1082 G/A promoter polymorphism of interleukin-10 gene with the autoantibodies production in patients with rheumatoid arthritis.

Authors:  Petr Nemec; Monika Pavkova-Goldbergova; Jindra Gatterova; Zdenek Fojtik; Anna Vasku; Miroslav Soucek
Journal:  Clin Rheumatol       Date:  2009-03-24       Impact factor: 2.980

6.  Application of whole genome and RNA sequencing to investigate the genomic landscape of common variable immunodeficiency disorders.

Authors:  Pauline A van Schouwenburg; Emma E Davenport; Anne-Kathrin Kienzler; Ishita Marwah; Benjamin Wright; Mary Lucas; Tomas Malinauskas; Hilary C Martin; Helen E Lockstone; Jean-Baptiste Cazier; Helen M Chapel; Julian C Knight; Smita Y Patel
Journal:  Clin Immunol       Date:  2015-06-26       Impact factor: 3.969

7.  Common genetic variants in PRRC2A are associated with both neuromyelitis optica spectrum disorder and multiple sclerosis in Han Chinese population.

Authors:  Juan Zhang; Mei-Jiao Chen; Gui-Xian Zhao; Hong-Fu Li; Lei Wu; Yong-Feng Xu; Yajin Liao; Zengqiang Yuan; Zhi-Ying Wu
Journal:  J Neurol       Date:  2020-08-29       Impact factor: 4.849

8.  The HLA Region and Autoimmune Disease: Associations and Mechanisms of Action.

Authors:  S C L Gough; M J Simmonds
Journal:  Curr Genomics       Date:  2007-11       Impact factor: 2.236

Review 9.  Defining the role of the MHC in autoimmunity: a review and pooled analysis.

Authors:  Michelle M A Fernando; Christine R Stevens; Emily C Walsh; Philip L De Jager; Philippe Goyette; Robert M Plenge; Timothy J Vyse; John D Rioux
Journal:  PLoS Genet       Date:  2008-04-25       Impact factor: 5.917

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.